ERG Responses in Mice with Deletion of the Synaptic Ribbon Component RIBEYE.


Journal

Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701

Informations de publication

Date de publication:
11 05 2020
Historique:
entrez: 22 5 2020
pubmed: 22 5 2020
medline: 29 9 2020
Statut: ppublish

Résumé

To determine the influence of RIBEYE deletion and the resulting absence of synaptic ribbons on retinal light signaling by electroretinography. Full-field flash electroretinograms (ERGs) were recorded in RIBEYE knock-out (KO) and wild-type (WT) littermate mice under photopic and scotopic conditions, with oscillatory potentials (OPs) extracted by digital filtering. Flicker ERGs and ERGs following intravitreal injection of pharmacological agents were also obtained under scotopic conditions. The a-wave amplitudes were unchanged between RIBEYE KO and WT mice; however, the b-wave amplitudes were reduced in KOs under scotopic, but not photopic, conditions. Increasing stimulation frequency led to a greater reduction in RIBEYE KO b-wave amplitudes compared with WTs. Furthermore, we observed prominent, supernormal OPs in RIBEYE KO mice in comparison with WT mice. Following intravitreal injections with l-2 amino-4-phosphonobutyric acid and cis-2,3 piperidine dicarboxylic acid to block ON and OFF responses at photoreceptor synapses, OPs were completely abolished in both mice types, indicating a synaptic origin of the prominent OPs in the KOs. Conversely, tetrodotoxin treatment to block voltage-gated Na+ channels/spiking neurons did not differentially affect OPs in WT and KO mice. The decreased scotopic b-wave and decreased responses to increased stimulation frequencies are consistent with signaling malfunctions at photoreceptor and inner retinal ribbon synapses. Because phototransduction in the photoreceptor outer segments is unaffected in the KOs, their supernormal OPs presumably result from a dysfunction in retinal synapses. The relatively mild ERG phenotype in KO mice, particularly in the photopic range, is probably caused by compensatory mechanisms in retinal signaling pathways.

Identifiants

pubmed: 32437548
pii: 2766228
doi: 10.1167/iovs.61.5.37
pmc: PMC7405791
doi:

Substances chimiques

Aminobutyrates 0
Co-Repressor Proteins 0
Excitatory Amino Acid Agonists 0
Piperidines 0
Sodium Channel Blockers 0
Tetrodotoxin 4368-28-9
Alcohol Oxidoreductases EC 1.1.-
Ctbp2 protein, mouse EC 1.1.-
2-amino-4-phosphonobutyric acid H8B59H10OK

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

37

Références

Vis Neurosci. 2008 Sep-Dec;25(5-6):635-45
pubmed: 19094370
Nature. 2013 Aug 8;500(7461):168-74
pubmed: 23925239
Oncotarget. 2017 Sep 8;8(44):77696-77709
pubmed: 29100418
Nat Neurosci. 2004 Aug;7(8):826-33
pubmed: 15235608
PLoS One. 2015 Jun 19;10(6):e0128921
pubmed: 26091521
Neuron. 2000 Sep;27(3):513-23
pubmed: 11055434
Doc Ophthalmol. 2014 Jun;128(3):155-68
pubmed: 24659322
Prog Retin Eye Res. 1998 Oct;17(4):485-521
pubmed: 9777648
Neuroscientist. 2009 Dec;15(6):611-24
pubmed: 19700740
Elife. 2016 Nov 25;5:
pubmed: 27885985
Nature. 2000 Aug 24;406(6798):849-54
pubmed: 10972279
J Physiol. 2002 Sep 15;543(Pt 3):899-916
pubmed: 12231647
Neuron. 2003 Mar 6;37(5):775-86
pubmed: 12628168
Elife. 2018 Jan 12;7:
pubmed: 29328021
J Comp Neurol. 2019 Jan 1;527(1):117-132
pubmed: 28856684
J Physiol. 2014 Apr 1;592(7):1457-77
pubmed: 24396054
J Neurosci. 2011 May 25;31(21):7670-81
pubmed: 21613480
Exp Eye Res. 2008 Jun;86(6):914-28
pubmed: 18440505
Hum Mutat. 2015 Jul;36(7):720-7
pubmed: 25921210
J Physiol. 2017 Aug 15;595(16):5517-5524
pubmed: 28295344
Nat Neurosci. 2008 Aug;11(8):923-31
pubmed: 18641643
Nat Commun. 2015 Jan 23;6:6006
pubmed: 25613321
Doc Ophthalmol. 2002 Sep;105(2):189-222
pubmed: 12462444
J Neurosci. 2011 Mar 30;31(13):5000-12
pubmed: 21451038
Prog Retin Eye Res. 2014 Sep;42:44-84
pubmed: 24984227
Biomed Res Int. 2016;2016:2790194
pubmed: 28101507
J Neurosci. 2011 Oct 12;31(41):14654-9
pubmed: 21994381
J Neurosci. 2010 Mar 31;30(13):4650-9
pubmed: 20357115
Invest Ophthalmol Vis Sci. 2009 Sep;50(9):4402-9
pubmed: 19407007
Acta Physiol (Oxf). 2012 Apr;204(4):479-86
pubmed: 21880116
Nat Neurosci. 2009 Mar;12(3):303-10
pubmed: 19219039
J Physiol. 2004 Feb 15;555(Pt 1):153-73
pubmed: 14578484
Invest Ophthalmol Vis Sci. 1978 Dec;17(12):1176-88
pubmed: 721390
Proc Natl Acad Sci U S A. 2013 Feb 12;110(7):E593-601
pubmed: 23359713
Curr Biol. 2015 Nov 2;25(21):2763-2773
pubmed: 26441349
EMBO J. 2016 May 17;35(10):1098-114
pubmed: 26929012
J Biol Chem. 2011 Sep 23;286(38):33252-9
pubmed: 21799013
Physiol Rev. 2019 Jul 1;99(3):1527-1573
pubmed: 31140374
Elife. 2018 Jan 12;7:
pubmed: 29328020
J Neurosci. 2009 May 13;29(19):6088-93
pubmed: 19439586
Curr Eye Res. 2016 Apr;41(4):569-73
pubmed: 25974324
Neuron. 1998 Sep;21(3):481-93
pubmed: 9768836
Neuron. 1999 Jul;23(3):549-57
pubmed: 10433266
J Neurosci. 2014 May 28;34(22):7611-21
pubmed: 24872565
Invest Ophthalmol Vis Sci. 2006 Jun;47(6):2732-8
pubmed: 16723493
Nat Rev Neurosci. 2010 Dec;11(12):812-22
pubmed: 21045860
Vis Neurosci. 2004 Jul-Aug;21(4):533-43
pubmed: 15579219
Front Neuroanat. 2015 Oct 06;9:122
pubmed: 26500507
Invest Ophthalmol Vis Sci. 2017 Jan 1;58(1):318-328
pubmed: 28114593
Prog Retin Eye Res. 2010 Nov;29(6):622-39
pubmed: 20826226
Neuron. 1995 Mar;14(3):561-9
pubmed: 7695902
J Physiol. 2012 May 15;590(10):2501-17
pubmed: 22393249
Neuron. 2000 Jul;27(1):85-95
pubmed: 10939333
Neuron. 2000 Dec;28(3):857-72
pubmed: 11163272
J Neurophysiol. 2014 Sep 15;112(6):1491-504
pubmed: 25008417
Methods Mol Biol. 2018;1715:207-213
pubmed: 29188515
J Ophthalmol. 2011;2011:
pubmed: 20936060
Nat Commun. 2019 May 15;10(1):2167
pubmed: 31092821
J Cell Sci. 2009 May 1;122(Pt 9):1352-61
pubmed: 19386896
Trends Neurosci. 2005 Jan;28(1):20-9
pubmed: 15626493
Physiol Rev. 2020 Jan 1;100(1):103-144
pubmed: 31373863

Auteurs

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH